VRCAVerrica Pharmaceuticals Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 23451
Ticker: VRCA
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2018-06-15
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: VRCA

Detail

Enriched 2026-08-14 20:47

Market cap: $87,440,020.74
Shares outstanding (class): 17,178,786
Shares outstanding (weighted): 17,178,786
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 76
Location: WEST CHESTER, PA
Homepage: https://www.verrica.com
Description: Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Market cap and share counts drift.

Funds holding this security

5 funds · 5 positions · $1.01M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$719.1K	0.00%	135,937 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$279.4K	0.00%	52,821 NS	FIGI
Small Cap Core Fund Northern Funds	—	$8.5K	0.00%	1,607 NS	FIGI
Total Stock Market Index Trust John Hancock Variable Insurance Trust	—	$1.0K	0.00%	198 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$476.10	0.00%	90 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERVRCA
FIGI_COMPOSITEBBG00L03BYB7
FIGI_SHARE_CLASSBBG00L03BZ24
CIK0001660334
ISINUS92511W2070
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Verrica Pharmaceuticals is a biopharmaceutical company developing dermatology treatments, classified under pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.